---
category: news
title: "CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA(R) (iobenguane I 131)"
abstract: "NEW YORK, Aug 07, 2019 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. PGNX, -0.81%, an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and ..."
publishedDateTime: 2019-08-08T03:02:00Z
sourceUrl: https://www.marketwatch.com/press-release/cms-grants-new-technology-add-on-payment-for-inpatient-use-of-azedrar-iobenguane-i-131-2019-08-07
type: article
quality: 14
score: 14
published: false

provider:
  name: MarketWatch
  id: marketwatch.com

topics:
  - AI
  - AI in Healthcare
---
